Odevixibat (Bylvay)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Odevixibat (Bylvay), covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea